Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000955091> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- W2000955091 endingPage "1580" @default.
- W2000955091 startingPage "1580" @default.
- W2000955091 abstract "EFFICACY testing is under way in Seattle, Wash, with an experimental vaccine that, it is hoped, will stimulate the immune system to combat metastasizing adenocarcinoma of the prostate. Gerald P. Murphy, MD, DSc, director of research, Pacific Northwest Cancer Foundation, told a recent American Cancer Society (ACS) meeting in Reston, Va, that the phase II trial began earlier this year at Seattle's Northwest Hospital. This trial involves 67 volunteers—35 men whose cancer has spread beyond the prostatic bed and is resistant to hormone therapy and 32 with evidence (rising prostate-specific antigen [PSA] levels) of local cancer recurrence after initial surgery or radiotherapy. Earlier, Murphy and colleagues conducted phase I clinical acute or chronictoxicity trials with 51 volunteers whose advanced prostatic cancer had not responded to currently available forms of treatment. These men were divided into 5 groups, each of which received a variation of the vaccine regimen. In an unexpected" @default.
- W2000955091 created "2016-06-24" @default.
- W2000955091 creator A5048302094 @default.
- W2000955091 date "1997-05-28" @default.
- W2000955091 modified "2023-09-26" @default.
- W2000955091 title "Prostate cancer's complexities of causation, detection, and treatment challenge researchers" @default.
- W2000955091 doi "https://doi.org/10.1001/jama.277.20.1580" @default.
- W2000955091 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9168273" @default.
- W2000955091 hasPublicationYear "1997" @default.
- W2000955091 type Work @default.
- W2000955091 sameAs 2000955091 @default.
- W2000955091 citedByCount "0" @default.
- W2000955091 crossrefType "journal-article" @default.
- W2000955091 hasAuthorship W2000955091A5048302094 @default.
- W2000955091 hasConcept C111472728 @default.
- W2000955091 hasConcept C121608353 @default.
- W2000955091 hasConcept C126322002 @default.
- W2000955091 hasConcept C138885662 @default.
- W2000955091 hasConcept C166151441 @default.
- W2000955091 hasConcept C177713679 @default.
- W2000955091 hasConcept C2780192828 @default.
- W2000955091 hasConcept C71924100 @default.
- W2000955091 hasConceptScore W2000955091C111472728 @default.
- W2000955091 hasConceptScore W2000955091C121608353 @default.
- W2000955091 hasConceptScore W2000955091C126322002 @default.
- W2000955091 hasConceptScore W2000955091C138885662 @default.
- W2000955091 hasConceptScore W2000955091C166151441 @default.
- W2000955091 hasConceptScore W2000955091C177713679 @default.
- W2000955091 hasConceptScore W2000955091C2780192828 @default.
- W2000955091 hasConceptScore W2000955091C71924100 @default.
- W2000955091 hasIssue "20" @default.
- W2000955091 hasLocation W20009550911 @default.
- W2000955091 hasLocation W20009550912 @default.
- W2000955091 hasOpenAccess W2000955091 @default.
- W2000955091 hasPrimaryLocation W20009550911 @default.
- W2000955091 hasRelatedWork W1996846311 @default.
- W2000955091 hasRelatedWork W2087041286 @default.
- W2000955091 hasRelatedWork W2091020218 @default.
- W2000955091 hasRelatedWork W2365364931 @default.
- W2000955091 hasRelatedWork W2418638721 @default.
- W2000955091 hasRelatedWork W2962601203 @default.
- W2000955091 hasRelatedWork W3166413310 @default.
- W2000955091 hasRelatedWork W4243514755 @default.
- W2000955091 hasRelatedWork W4252371801 @default.
- W2000955091 hasRelatedWork W2189427681 @default.
- W2000955091 hasVolume "277" @default.
- W2000955091 isParatext "false" @default.
- W2000955091 isRetracted "false" @default.
- W2000955091 magId "2000955091" @default.
- W2000955091 workType "article" @default.